Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 163

Similar articles for PubMed (Select 18162804)

1.

Risk assessment to guide the prevention of cervical cancer.

Castle PE, Sideri M, Jeronimo J, Solomon D, Schiffman M.

J Low Genit Tract Dis. 2008 Jan;12(1):1-7.

PMID:
18162804
2.

Secondary prevention of cervical cancer part 1: screening for cervical cancer and its precursors.

Boisen M, Diedrich JT, Lonky NM, Guido R.

Clin Obstet Gynecol. 2014 Jun;57(2):279-91. doi: 10.1097/GRF.0000000000000032.

PMID:
24785416
3.

Secondary prevention of cervical cancer part 3: evidence-based management of women with cervical intraepithelial neoplasia.

Guido R, Lonky NM, Diedrich J.

Clin Obstet Gynecol. 2014 Jun;57(2):302-15. doi: 10.1097/GRF.0000000000000034.

PMID:
24709711
4.

A validation study of the Focalpoint GS imaging system for gynecologic cytology screening.

Renshaw A, Elsheikh TM.

Cancer Cytopathol. 2013 Dec;121(12):737-8. doi: 10.1002/cncy.21336. Epub 2013 Jul 10. No abstract available.

PMID:
23843282
5.

Reply to a validation study of the Focalpoint GS imaging system for gynecologic cytology screening.

Colgan T.

Cancer Cytopathol. 2013 Dec;121(12):738. doi: 10.1002/cncy.21335. Epub 2013 Jul 10. No abstract available.

PMID:
23843272
6.

Development of an expert system as a diagnostic support of cervical cancer in atypical glandular cells, based on fuzzy logics and image interpretation.

Domínguez Hernández KR, Aguilar Lasserre AA, Posada Gómez R, Palet Guzmán JA, González Sánchez BE.

Comput Math Methods Med. 2013;2013:796387. doi: 10.1155/2013/796387. Epub 2013 Apr 18. Review.

7.

Risk of cancer in women with cervical precancer: improving risk assessment and management protocols.

Prendiville W.

Cytopathology. 2011 Jun;22(3):143-5. doi: 10.1111/j.1365-2303.2011.00870.x. No abstract available.

PMID:
21592240
8.

[Prevention and management of cervical cancer promoted by value-based medicine].

Shen K.

Zhonghua Yi Xue Za Zhi. 2010 Nov 23;90(43):3025-6. Chinese. No abstract available.

PMID:
21211318
9.

The Pittsburgh Cervical Cancer Screening Model: a risk assessment tool.

Austin RM, Onisko A, Druzdzel MJ.

Arch Pathol Lab Med. 2010 May;134(5):744-50. doi: 10.1043/1543-2165-134.5.744.

PMID:
20441506
10.

HPV vaccine protein L1 predicts disease outcome of high-risk HPV+ early squamous dysplastic lesions.

Griesser H, Sander H, Walczak C, Hilfrich RA.

Am J Clin Pathol. 2009 Dec;132(6):840-5. doi: 10.1309/AJCPCU0HBFFFGDTV.

12.

High-risk human papillomavirus testing for monitoring patients treated for high-grade cervical intraepithelial neoplasia.

Jeong NH, Lee NW, Kim HJ, Kim T, Lee KW.

J Obstet Gynaecol Res. 2009 Aug;35(4):706-11. doi: 10.1111/j.1447-0756.2008.00989.x.

PMID:
19751331
14.

What's next? Perspectives and future needs of cervical screening in Europe in the era of molecular testing and vaccination.

Lynge E, Antilla A, Arbyn M, Segnan N, Ronco G.

Eur J Cancer. 2009 Oct;45(15):2714-21. doi: 10.1016/j.ejca.2009.07.024. Epub 2009 Aug 18. Review.

PMID:
19695870
15.

Human papillomavirus testing for cervical cancer screening: results from a 6-year prospective study in rural China.

Shi JF, Belinson JL, Zhao FH, Pretorius RG, Li J, Ma JF, Chen F, Xiang W, Pan QJ, Zhang X, Zhang WH, Qiao YL, Smith JS.

Am J Epidemiol. 2009 Sep 15;170(6):708-16. doi: 10.1093/aje/kwp188. Epub 2009 Aug 19.

16.

Management of the low grade squamous intraepithelial lesion Pap smear in a cross-sectional, observational cohort.

Yoost JL, Goetzl L, Hoda R, Soper DE, Barry A.

J Reprod Med. 2009 Jul;54(7):421-4.

PMID:
19691257
17.

Value of high-risk HPV-DNA testing in the triage of ASCUS.

Silverloo I, Andrae B, Wilander E.

Acta Obstet Gynecol Scand. 2009;88(9):1006-10. doi: 10.1080/00016340903160952.

PMID:
19690991
18.

Comparison of cytology, colposcopy, HPV typing and biomarker analysis in cervical neoplasia.

Adamopoulou M, Kalkani E, Charvalos E, Avgoustidis D, Haidopoulos D, Yapijakis C.

Anticancer Res. 2009 Aug;29(8):3401-9.

19.

Update on ASCCP consensus guidelines for abnormal cervical screening tests and cervical histology.

Apgar BS, Kittendorf AL, Bettcher CM, Wong J, Kaufman AJ.

Am Fam Physician. 2009 Jul 15;80(2):147-55.

20.

DNA methylation analysis in liquid-based cytology for cervical cancer screening.

Apostolidou S, Hadwin R, Burnell M, Jones A, Baff D, Pyndiah N, Mould T, Jacobs IJ, Beddows S, Kocjan G, Widschwendter M.

Int J Cancer. 2009 Dec 15;125(12):2995-3002. doi: 10.1002/ijc.24745.

PMID:
19609949
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk